CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
CPDC focuses on the discovery, development, distribution, and commercialization of molecular imaging probes and targeted radiotherapeutics.
CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
Industry:
Biotechnology Pharmaceutical Product Research Therapeutics
Founded:
2008-01-01
Address:
Hamilton, Ontario, Canada
Country:
Canada
Website Url:
http://www.imagingprobes.ca
Total Employee:
51+
Status:
Active
Contact:
1-905-525-9140
Email Addresses:
[email protected]
Total Funding:
10.5 M CAD
Technology used in webpage:
Google Apps For Business Person Schema Facebook Sharer Gravatar Profiles WebEx
Similar Organizations
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Government of Canada
Government of Canada investment in Grant - Centre for Probe Development and Commercialization
Official Site Inspections
http://www.imagingprobes.ca Semrush global rank: 10.22 M Semrush visits lastest month: 22
- Host name: parama.ca
- IP address: 209.15.37.6
- Location: Vancouver Canada
- Latitude: 49.245
- Longitude: -123.1337
- Timezone: America/Vancouver
- Postal: V6H
More informations about "Centre for Probe Development and Commercialization"
CPDC joins forces with the Canadian Nuclear Isotope Council
Feb 19, 2019 Since its inception, CPDC has gained global recognition as a leading radiopharmaceutical organization, developing and providing products for the diagnosis and โฆSee details»
Centre For Probe Development and Commercialization
At the CPDC we discover, develop, and distribute radiopharmaceuticals. The CPDC was founded in 2008 as a Centre of Excellence for Commercialization and Research (CECR), specializing โฆSee details»
Unleashing Canadaโs Radiopharmaceutical Excellence
Sep 17, 2020 For more information about CPDC, please visit: www.imagingprobes.ca or contact [email protected]. For additional information, please contact: Shirley Robinet โฆSee details»
Centre for Probe Development and Commercialization
Centre for Probe Development and Commercialization may be growing as it has been involved in a partnership that was awarded a significant investment from the federal government, which is โฆSee details»
imagingprobes.ca - CPDC - Centre for Probe Develo... - Imaging โฆ
Popular pages. Centre for Probe Development and Commercialization. YOUR RADIOPHARMACEUTICAL DEVELOPMENT PARTNER. At CPDC we are working with our โฆSee details»
Centre for Probe Development and Commercialization
Jun 27, 2022 View Centre for Probe Development and Commercialization (www.imagingprobes.ca) location in Ontario, Canada , revenue, industry and description. Find โฆSee details»
Isotopia successfully deliver n.c.a. Lu-177 to North American โฆ
Jun 9, 2022 CPDC is a global leading CDMO (Contract Development and Manufacturing Organization) for the GMP manufacturing and supply of radiopharmaceuticals. ... For more โฆSee details»
The Centre for Probe Development and Commercialization
May 25, 2022 For more information about CPDC, please visit: www.imagingprobes.ca or contact ... Organization Profile. Centre for Probe Development and Commercialization. Contact Cision. โฆSee details»
imagingprobes.ca - Whois.com
Apr 1, 2008 Domain Name: imagingprobes.ca Registry Domain ID: D671359-CIRA Registrar WHOIS Server: whois.ca.fury.ca Registrar URL: www.webnames.ca Updated Date: 2024-11 โฆSee details»
CPDC Announces Appointment of Bruno Paquin as Permanent โฆ
Mar 10, 2021 imagingprobes.ca. × Modal title. Organization Profile. Centre for Probe Development and Commercialization. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET โฆSee details»
CPDC's Radiopharmaceutical Manufacturing Facility Receives โฆ
Jan 9, 2020 imagingprobes.ca. × Modal title. Organization Profile. Centre for Probe Development and Commercialization. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET โฆSee details»
Centre for Probe Development and Commercialization - Wikidata
Language Label Description Also known as; English: Centre for Probe Development and Commercialization. nonprofit organization in Hamilton, CanadaSee details»
NuGeneris Specialty Pharmaceuticals - Synapse Life Science ...
NuGeneris Specialty Pharmaceuticals is a privately held subsidiary of the CPDC specializing in late-phase clinical and commercial manufacturing of therapeutic radiopharmaceuticals for โฆSee details»
POINT Biopharma Signs Exclusive License Agreement with โฆ
Jan 12, 2021 CanProbe (canprobe.ca) is a joint venture between the University Health Network (UHN, uhn.ca) and the Centre for Probe Development and Commercialization (CPDC, โฆSee details»
Imagingprobes.ca - Centre for Probe... Traffic, Ranking ... - HypeStat
Imagingprobes.ca receives about 986 unique visitors per day, and it is ranked 2,271,670 in the world. imagingprobes.ca uses Apache, Google Analytics, Google Font API ...See details»
CPDC Announces First Patient Dosed in a Phase 3 Clinical
Feb 24, 2021 www.imagingprobes.ca. × Modal title. Organization Profile. Centre for Probe Development and Commercialization. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET โฆSee details»
Canada Drug Product - OPENGOVCA
Feb 24, 2022 This dataset includes 10 thousand drug products authorized for sale by Health Canada. Drugs can be identified by a Drug Identification Number (DIN), including drugs for โฆSee details»
Ask a cancer researcher: What are โimaging probesโ and how can โฆ
Jan 29, 2024 PhD student Pamela Penawou answers a question from a prostate cancer survivor. One of the most exciting new innovations in diagnosing cancer is the development of โฆSee details»
Is imagingprobes.ca Safe? - Web of Trust
Ratings and Reviews for imagingprobes - WOT Scorecard provides customer service reviews for imagingprobes.ca. Use MyWOT to run safety checks on any website.See details»
PRODUCT MONOGRAPH GLUCOVISION - pdf.hres.ca
Www.imagingprobes.ca Submission Control No: 195237 Date of Approval: August 16, 2016 Date of Revision: ... and/or appropriate licenses of local competent official organizations. As in the โฆSee details»